(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session.

The three most active and biggest winners today are BeiGene, Aspen Group, and China Petroleum & Chemical.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 BeiGene (BGNE) 296.00 4.97% 2021-08-30 07:11:31
2 Aspen Group (ASPU) 5.98 4.36% 2021-08-30 07:11:27
3 China Petroleum & Chemical (SNP) 47.20 4.01% 2021-08-30 07:17:10
4 SmileDirectClub (SDC) 5.36 3.47% 2021-08-30 07:12:47
5 iShares Core MSCI Total (IXUS) 75.50 3.11% 2021-08-30 04:12:13
6 PetroChina (PTR) 42.19 3.1% 2021-08-30 07:16:47
7 Viking Therapeutics (VKTX) 6.42 3.05% 2021-08-30 07:13:18
8 Catalent (CTLT) 133.49 2.8% 2021-08-30 07:14:41
9 Arcturus Therapeutics (ARCT) 58.19 2.65% 2021-08-30 07:11:26
10 Xenetic Biosciences (XBIO) 3.07 2.33% 2021-08-30 07:13:20

The three most active and biggest losers today are Insulet, NetEase, and Stanley Black & Decker.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 Insulet (PODD) 259.08 -12.2% 2021-08-30 06:10:14
2 NetEase (NTES) 84.80 -8.58% 2021-08-30 07:09:51
3 Stanley Black & Decker (SWK) 188.47 -2.88% 2021-08-30 07:17:18
4 Moderna (MRNA) 371.70 -2.75% 2021-08-30 07:12:23
5 Honeywell International (HON) 227.06 -1.77% 2021-08-30 07:15:39
6 Crown Castle International (CCI) 188.25 -1.42% 2021-08-30 07:14:21
7 ANSYS (ANSS) 360.00 -1.38% 2021-08-30 06:07:23
8 Brookfield (BAM) 56.20 -1.33% 2021-08-30 07:14:00
9 Marathon (MARA) 39.70 -1.24% 2021-08-30 07:09:28
10 Riot Blockchain (RIOT) 38.11 -1.19% 2021-08-30 07:12:44

Most Active Premarket Winners today

1. BeiGene (BGNE) – Premarket: 4.97%

NASDAQ Composite ended the session with BeiGene falling 0.3% to $281.98 on Monday while NASDAQ Composite rose 1.23% to $15,129.50.

Volume

Today’s last reported volume for BeiGene is 224161, 22.35% below its average volume of 288717.

BeiGene’s last close was $282.82, 27.29% below its 52-week high of $388.97.

BeiGene’s Sales

BeiGene’s sales growth is 188.9% for the present quarter and 161.2% for the next. The company’s growth estimates for the present quarter is a negative 19.3% and positive 2.9% for the next.

BeiGene’s Revenue

Year-on-year quarterly revenue growth grew by 1063.8%, now sitting on 862.69M for the twelve trailing months.

Volatility

BeiGene’s last week, last month’s, and last quarter’s current volatility was a negative 0.69%, a negative 0.67%, and a positive 2.62%, respectively.

BeiGene’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 8.76% (last week), 3.55% (last month), and 2.62% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

BeiGene’s stock is considered to be overbought (>=80).

BeiGene’s Stock Yearly Top and Bottom Value

BeiGene’s stock is valued at $281.98 at 08:34 EST, way under its 52-week high of $388.97 and way higher than its 52-week low of $219.20.

BeiGene’s Moving Average

BeiGene’s value is below its 50-day moving average of $308.80 and way below its 200-day moving average of $326.43.

More news about BeiGene.

2. Aspen Group (ASPU) – Premarket: 4.36%

NASDAQ Composite ended the session with Aspen Group dropping 2.88% to $5.73 on Monday, after two sequential sessions in a row of losses. NASDAQ Composite rose 1.23% to $15,129.50, following the last session’s upward trend on what was an all-around bullish trend exchanging session today.

Volume

Today’s last reported volume for Aspen Group is 116168, 57.31% below its average volume of 272155.

Aspen Group’s last close was $5.90, 55.17% under its 52-week high of $13.16.

Aspen Group’s Revenue

Year-on-year quarterly revenue growth grew by 32.6%, now sitting on 62.84M for the twelve trailing months.

Volatility

Aspen Group’s last week, last month’s, and last quarter’s current volatility was a negative 1.47%, a negative 0.09%, and a positive 3.01%, respectively.

Aspen Group’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.31% (last week), 2.94% (last month), and 3.01% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Aspen Group’s stock is considered to be overbought (>=80).

Aspen Group’s Stock Yearly Top and Bottom Value

Aspen Group’s stock is valued at $5.73 at 08:34 EST, way under its 52-week high of $13.16 and way above its 52-week low of $4.70.

Aspen Group’s Moving Average

Aspen Group’s value is below its 50-day moving average of $6.34 and way under its 200-day moving average of $6.62.

More news about Aspen Group.

3. China Petroleum & Chemical (SNP) – Premarket: 4.01%

NYSE Composite ended the session with China Petroleum & Chemical rising 1.25% to $45.38 on Monday while NYSE Composite rose 0.9% to $16,844.75.

Volume

Today’s last reported volume for China Petroleum & Chemical is 80101, 49.74% below its average volume of 159374.

China Petroleum & Chemical’s last close was $44.82, 23.25% below its 52-week high of $58.40.

The company’s growth estimates for the present quarter and the next is 10.8% and 110.6%, respectively.

China Petroleum & Chemical’s Revenue

Year-on-year quarterly revenue growth grew by 4.1%, now sitting on 2.13T for the twelve trailing months.

Volatility

China Petroleum & Chemical’s last week, last month’s, and last quarter’s current volatility was a negative 0.16%, a negative 0.42%, and a positive 1.37%, respectively.

China Petroleum & Chemical’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.41% (last week), 1.41% (last month), and 1.37% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

China Petroleum & Chemical’s stock is considered to be overbought (>=80).

China Petroleum & Chemical’s Stock Yearly Top and Bottom Value

China Petroleum & Chemical’s stock is valued at $45.38 at 08:34 EST, way under its 52-week high of $58.40 and way above its 52-week low of $38.18.

China Petroleum & Chemical’s Moving Average

China Petroleum & Chemical’s value is way below its 50-day moving average of $50.48 and way below its 200-day moving average of $52.19.

More news about China Petroleum & Chemical.

4. SmileDirectClub (SDC) – Premarket: 3.47%

NASDAQ Composite ended the session with SmileDirectClub rising 5.5% to $5.18 on Monday while NASDAQ Composite rose 1.23% to $15,129.50.

Volume

Today’s last reported volume for SmileDirectClub is 7517070, 12.68% above its average volume of 6670860.

SmileDirectClub’s last close was $4.91, 69.47% under its 52-week high of $16.08.

The company’s growth estimates for the current quarter is 64% and a drop 18.2% for the next.

SmileDirectClub’s Revenue

Year-on-year quarterly revenue growth grew by 62.7%, now sitting on 726.7M for the twelve trailing months.

Volatility

SmileDirectClub’s last week, last month’s, and last quarter’s current volatility was a negative 0.80%, a negative 1.21%, and a positive 3.07%, respectively.

SmileDirectClub’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.37% (last week), 2.82% (last month), and 3.07% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

SmileDirectClub’s stock is considered to be overbought (>=80).

SmileDirectClub’s Stock Yearly Top and Bottom Value

SmileDirectClub’s stock is valued at $5.18 at 08:34 EST, way under its 52-week high of $16.08 and way higher than its 52-week low of $4.63.

SmileDirectClub’s Moving Average

SmileDirectClub’s worth is way under its 50-day moving average of $6.51 and way under its 200-day moving average of $9.11.

More news about SmileDirectClub.

5. iShares Core MSCI Total (IXUS) – Premarket: 3.11%

NASDAQ Composite ended the session with iShares Core MSCI Total jumping 1.15% to $73.22 on Monday while NASDAQ Composite jumped 1.23% to $15,129.50.

Volume

Today’s last reported volume for iShares Core MSCI Total is 891238, 41.28% below its average volume of 1517950.

Volatility

iShares Core MSCI Total’s last week, last month’s, and last quarter’s current volatility was a negative 0.04%, a negative 0.10%, and a positive 0.66%, respectively.

iShares Core MSCI Total’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.57% (last week), 0.70% (last month), and 0.66% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

iShares Core MSCI Total’s stock is considered to be overbought (>=80).

More news about iShares Core MSCI Total.

6. PetroChina (PTR) – Premarket: 3.1%

NYSE Composite ended the session with PetroChina rising 2.84% to $40.92 on Monday while NYSE Composite rose 0.9% to $16,844.75.

Volume

Today’s last reported volume for PetroChina is 179126, 26.45% below its average volume of 243563.

PetroChina’s last close was $39.79, 22.22% below its 52-week high of $51.16.

PetroChina’s Revenue

Year-on-year quarterly revenue growth grew by 8.4%, now sitting on 1.98T for the twelve trailing months.

Volatility

PetroChina’s last week, last month’s, and last quarter’s current volatility was a negative 0.07%, a negative 0.52%, and a positive 1.89%, respectively.

PetroChina’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.80% (last week), 2.07% (last month), and 1.89% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

PetroChina’s stock is considered to be overbought (>=80).

PetroChina’s Stock Yearly Top and Bottom Value

PetroChina’s stock is valued at $40.92 at 08:34 EST, way under its 52-week high of $51.16 and way higher than its 52-week low of $27.68.

PetroChina’s Moving Average

PetroChina’s value is way under its 50-day moving average of $45.56 and higher than its 200-day moving average of $38.74.

More news about PetroChina.

7. Viking Therapeutics (VKTX) – Premarket: 3.05%

NASDAQ Composite ended the session with Viking Therapeutics rising 3.15% to $6.23 on Monday while NASDAQ Composite jumped 1.23% to $15,129.50.

Volume

Today’s last reported volume for Viking Therapeutics is 696588, 21.78% below its average volume of 890606.

Viking Therapeutics’s last close was $6.04, 40.14% below its 52-week high of $10.09.

The company’s growth estimates for the present quarter and the next is a negative 61.5% and a negative 46.7%, respectively.

Volatility

Viking Therapeutics’s last week, last month’s, and last quarter’s current volatility was a negative 0.04%, a negative 0.27%, and a positive 2.37%, respectively.

Viking Therapeutics’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.07% (last week), 1.66% (last month), and 2.37% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Viking Therapeutics’s stock is considered to be oversold (<=20).

Viking Therapeutics’s Stock Yearly Top and Bottom Value

Viking Therapeutics’s stock is valued at $6.23 at 08:34 EST, way under its 52-week high of $10.09 and way higher than its 52-week low of $4.95.

Viking Therapeutics’s Moving Average

Viking Therapeutics’s worth is higher than its 50-day moving average of $5.92 and below its 200-day moving average of $6.26.

More news about Viking Therapeutics.

8. Catalent (CTLT) – Premarket: 2.8%

NYSE Composite ended the session with Catalent falling 0.35% to $129.85 on Monday, after five consecutive sessions in a row of gains. NYSE Composite rose 0.9% to $16,844.75, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.

Volume

Today’s last reported volume for Catalent is 1494350, 102.43% above its average volume of 738203.

Catalent’s last close was $130.30, 2.05% higher than its 52-week high of $127.68.

News about Catalent today

  • Catalent to acquire bettera for $1 bln : report. According to today’s article on Business Insider, "Contract drug manufacturer Catalent Inc. (CTLT) has agreed to acquire closely held vitamin and supplements maker Bettera Holdings for $1 billion in cash, the Wall Street Journal reported citing people familiar with the matter."
  • Catalent to acquire gummy maker bettera from highlander partners for $1 billion in cash. According to today’s article on MarketWatch, "Bettera has "broad and difficult-to-replicate expertise" in developing and producing products for nutraceutical, functional, and botanical ingredients, and has four production facilities in the U.S., Catalent said in a statement. "

Catalent’s Sales

Catalent’s sales growth is 20.2% for the present quarter and 23.4% for the next. The company’s growth estimates for the present quarter and the next is 14.4% and 53.5%, respectively.

Catalent’s Revenue

Year-on-year quarterly revenue growth grew by 38.5%, now sitting on 3.76B for the twelve trailing months.

Volatility

Catalent’s last week, last month’s, and last quarter’s current volatility was 0.28%, 0.33%, and 1.31%, respectively.

Catalent’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.72% (last week), 1.26% (last month), and 1.31% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Catalent’s stock is considered to be oversold (<=20).

Catalent’s Stock Yearly Top and Bottom Value

Catalent’s stock is valued at $129.85 at 08:34 EST, above its 52-week high of $127.68.

Catalent’s Moving Average

Catalent’s value is way above its 50-day moving average of $115.62 and way above its 200-day moving average of $110.32.

Previous days news about Catalent

  • Catalent to buy supplement maker bettera holdings for $1 billion. According to The Wall Street Journal on Sunday, 29 August, "Contract drug manufacturer Catalent Inc. is expected to announce Monday that it has agreed to buy closely held Bettera Holdings LLC for $1 billion, according to people familiar with the matter, the latest deal involving nutritional supplement companies."

More news about Catalent.

9. Arcturus Therapeutics (ARCT) – Premarket: 2.65%

NASDAQ Composite ended the session with Arcturus Therapeutics rising 3.58% to $56.69 on Monday while NASDAQ Composite rose 1.23% to $15,129.50.

Volume

Today’s last reported volume for Arcturus Therapeutics is 589427, 33.51% below its average volume of 886609.

Arcturus Therapeutics’s last close was $54.73, 57.81% under its 52-week high of $129.71.

Arcturus Therapeutics’s Sales

Arcturus Therapeutics’s sales growth is a negative 43.5% for the current quarter and 525.3% for the next. The company’s growth estimates for the current quarter and the next is a negative 290.9% and a negative 79.3%, respectively.

Arcturus Therapeutics’s Revenue

Year-on-year quarterly revenue growth declined by 24.6%, now sitting on 9.54M for the twelve trailing months.

Volatility

Arcturus Therapeutics’s last week, last month’s, and last quarter’s current volatility was a positive 1.27%, a negative 0.20%, and a positive 3.35%, respectively.

Arcturus Therapeutics’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.91% (last week), 3.22% (last month), and 3.35% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Arcturus Therapeutics’s stock is considered to be oversold (<=20).

Arcturus Therapeutics’s Stock Yearly Top and Bottom Value

Arcturus Therapeutics’s stock is valued at $56.69 at 08:34 EST, way under its 52-week high of $129.71 and way higher than its 52-week low of $24.87.

Arcturus Therapeutics’s Moving Average

Arcturus Therapeutics’s value is way higher than its 50-day moving average of $38.96 and way higher than its 200-day moving average of $40.74.

More news about Arcturus Therapeutics.

10. Xenetic Biosciences (XBIO) – Premarket: 2.33%

NASDAQ Composite ended the session with Xenetic Biosciences sliding 3.85% to $3.00 on Monday, after two successive sessions in a row of losses. NASDAQ Composite jumped 1.23% to $15,129.50, following the last session’s upward trend on what was an all-around bullish trend exchanging session today.

Volume

Today’s last reported volume for Xenetic Biosciences is 944954, 90.67% below its average volume of 10138200.

Xenetic Biosciences’s last close was $3.12, 46.67% below its 52-week high of $5.85.

The company’s growth estimates for the current quarter is a negative 6.7% and positive 90% for the next.

Xenetic Biosciences’s Revenue

Year-on-year quarterly revenue growth grew by 154.7%, now sitting on 746.09k for the twelve trailing months.

Volatility

Xenetic Biosciences’s last week, last month’s, and last quarter’s current volatility was 8.71%, 1.07%, and 4.79%, respectively.

Xenetic Biosciences’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 8.71% (last week), 6.66% (last month), and 4.79% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Xenetic Biosciences’s stock is considered to be overbought (>=80).

Xenetic Biosciences’s Stock Yearly Top and Bottom Value

Xenetic Biosciences’s stock is valued at $3.00 at 08:34 EST, way below its 52-week high of $5.85 and way higher than its 52-week low of $0.76.

Xenetic Biosciences’s Moving Average

Xenetic Biosciences’s worth is above its 50-day moving average of $2.90 and way higher than its 200-day moving average of $2.42.

More news about Xenetic Biosciences.

Most Active Premarket Losers Today

1. Insulet (PODD) – Premarket: -12.2%

NASDAQ Composite ended the session with Insulet jumping 0.33% to $295.09 on Monday while NASDAQ Composite jumped 1.23% to $15,129.50.

Volume

Today’s last reported volume for Insulet is 227492, 45.64% below its average volume of 418496.

Insulet’s last close was $294.13, 4.02% below its 52-week high of $306.46.

The company’s growth estimates for the present quarter is a negative 40.9% and positive 52.9% for the next.

Insulet’s Revenue

Year-on-year quarterly revenue growth grew by 27.4%, now sitting on 958.7M for the twelve trailing months.

Volatility

Insulet’s last week, last month’s, and last quarter’s current volatility was a positive 0.08%, a negative 0.20%, and a positive 1.92%, respectively.

Insulet’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.52% (last week), 1.77% (last month), and 1.92% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Insulet’s stock is considered to be overbought (>=80).

Insulet’s Stock Yearly Top and Bottom Value

Insulet’s stock is valued at $295.09 at 08:34 EST, below its 52-week high of $306.46 and way higher than its 52-week low of $197.08.

Insulet’s Moving Average

Insulet’s value is above its 50-day moving average of $278.88 and above its 200-day moving average of $271.80.

More news about Insulet.

2. NetEase (NTES) – Premarket: -8.58%

NASDAQ Composite ended the session with NetEase jumping 1.64% to $92.76 on Monday, after two sequential sessions in a row of losses. NASDAQ Composite rose 1.23% to $15,129.50, following the last session’s upward trend on what was an all-around positive trend exchanging session today.

Volume

Today’s last reported volume for NetEase is 2394070, 19.81% below its average volume of 2985760.

NetEase’s last close was $91.26, 32.06% under its 52-week high of $134.33.

NetEase’s Sales

NetEase’s sales growth is 637.9% for the present quarter and 673.3% for the next. The company’s growth estimates for the current quarter and the next is 381.1% and 684.1%, respectively.

NetEase’s Revenue

Year-on-year quarterly revenue growth grew by 20.2%, now sitting on 77.12B for the twelve trailing months.

Volatility

NetEase’s last week, last month’s, and last quarter’s current volatility was a negative 3.09%, a negative 0.72%, and a positive 2.24%, respectively.

NetEase’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 9.78% (last week), 3.03% (last month), and 2.24% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

NetEase’s stock is considered to be overbought (>=80).

NetEase’s Stock Yearly Top and Bottom Value

NetEase’s stock is valued at $92.76 at 08:34 EST, way under its 52-week high of $134.33 and way above its 52-week low of $77.97.

NetEase’s Moving Average

NetEase’s worth is under its 50-day moving average of $98.53 and way below its 200-day moving average of $107.96.

More news about NetEase.

3. Stanley Black & Decker (SWK) – Premarket: -2.88%

NYSE Composite ended the session with Stanley Black & Decker rising 0.39% to $194.05 on Monday while NYSE Composite rose 0.9% to $16,844.75.

Volume

Today’s last reported volume for Stanley Black & Decker is 786167, 13.94% below its average volume of 913528.

Stanley Black & Decker’s last close was $193.29, 14.09% below its 52-week high of $225.00.

Stanley Black & Decker’s Sales

Stanley Black & Decker’s sales growth is 11.2% for the current quarter and 2.8% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 11.1% and a negative 12.5%, respectively.

Stanley Black & Decker’s Revenue

Year-on-year quarterly revenue growth grew by 34.1%, now sitting on 15.6B for the twelve trailing months.

Volatility

Stanley Black & Decker’s last week, last month’s, and last quarter’s current volatility was a negative 0.88%, a negative 0.23%, and a positive 1.02%, respectively.

Stanley Black & Decker’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.79% (last week), 1.15% (last month), and 1.02% (last quarter), respectively.

Stanley Black & Decker’s Stock Yearly Top and Bottom Value

Stanley Black & Decker’s stock is valued at $194.05 at 08:34 EST, way under its 52-week high of $225.00 and way above its 52-week low of $148.88.

Stanley Black & Decker’s Moving Average

Stanley Black & Decker’s worth is under its 50-day moving average of $203.94 and under its 200-day moving average of $196.55.

More news about Stanley Black & Decker.

4. Moderna (MRNA) – Premarket: -2.75%

NASDAQ Composite ended the session with Moderna falling 4.52% to $382.22 on Monday, after two consecutive sessions in a row of gains. NASDAQ Composite jumped 1.23% to $15,129.50, following the last session’s upward trend on what was an all-around bullish trend trading session today.

Volume

Today’s last reported volume for Moderna is 13188500, 22.07% below its average volume of 16925200.

Moderna’s last close was $400.30, 19.54% below its 52-week high of $497.49.

News about Moderna today

  • Japan to probe deaths after shots from suspended Moderna vaccines. According to today’s article on Business Insider, "The health ministry last week had halted the use of 1.63 million doses of Moderna COVID-19 vaccines after the discovery of foreign materials in one batch.", "Japan is investigating reasons behind the deaths of two people after receiving Moderna COVID-19 vaccines that were allegedly contaminated, Nikkei reported."
  • Moderna, biontech rally stalls ahead of CDC meeting on boosters. According to today’s article on Bloomberg Quint, "Options imply that Moderna and BioNTech could move roughly 7% in either direction over the next week while Pfizer’s stock may move about 3%.", "But but he remains equal weight on Moderna and Pfizer because he doesn’t expect any major new vaccine orders in the near future, with an estimated 630 million of unused shots from the companies already purchased through 2022."

Moderna’s Sales

Moderna’s sales growth is 6241.2% for the ongoing quarter and 8216.6% for the next. The company’s growth estimates for the present quarter and the next is 2019.4% and 1698.3%, respectively.

Moderna’s Revenue

Year-on-year quarterly revenue growth grew by 6398.5%, now sitting on 7.02B for the twelve trailing months.

Volatility

Moderna’s last week, last month’s, and last quarter’s current volatility was 2.02%, 2.08%, and 3.24%, respectively.

Moderna’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 5.07% (last week), 3.66% (last month), and 3.24% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Moderna’s stock is considered to be oversold (<=20).

Moderna’s Stock Yearly Top and Bottom Value

Moderna’s stock is valued at $382.22 at 08:34 EST, way below its 52-week high of $497.49 and way above its 52-week low of $54.21.

Moderna’s Moving Average

Moderna’s value is way above its 50-day moving average of $341.43 and way above its 200-day moving average of $213.10.

Previous days news about Moderna

  • Japan probes deaths of two people who had Moderna shots. According to Bloomberg Quint on Saturday, 28 August, "Japan is investigating the deaths of two people who were administered Moderna Inc.’s Covid-19 shots from vaccine batches which have since been suspended.", "Takeda Pharmaceutical Co Ltd., the local distributor of the Moderna vaccine, said it’s important that the relationship between the deaths and the vaccines is officially investigated. "

More news about Moderna.

5. Honeywell International (HON) – Premarket: -1.77%

NYSE Composite ended the session with Honeywell International rising 0.11% to $231.14 on Monday while NYSE Composite jumped 0.9% to $16,844.75.

Volume

Today’s last reported volume for Honeywell International is 1655320, 43.63% below its average volume of 2936840.

Honeywell International’s last close was $230.88, 2.52% under its 52-week high of $236.86.

Honeywell International’s Sales

Honeywell International’s sales growth is 13.8% for the current quarter and 3.8% for the next. The company’s growth estimates for the present quarter and the next is 28.8% and 3.4%, respectively.

Honeywell International’s Revenue

Year-on-year quarterly revenue growth declined by 0.1%, now sitting on 32.63B for the twelve trailing months.

Volatility

Honeywell International’s last week, last month’s, and last quarter’s current volatility was a negative 0.25%, a positive 0.33%, and a positive 1.02%, respectively.

Honeywell International’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.52% (last week), 1.26% (last month), and 1.02% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Honeywell International’s stock is considered to be oversold (<=20).

Honeywell International’s Stock Yearly Top and Bottom Value

Honeywell International’s stock is valued at $231.14 at 08:34 EST, under its 52-week high of $236.86 and way above its 52-week low of $151.86.

Honeywell International’s Moving Average

Honeywell International’s worth is higher than its 50-day moving average of $224.24 and higher than its 200-day moving average of $218.38.

More news about Honeywell International.

6. Crown Castle International (CCI) – Premarket: -1.42%

NYSE Composite ended the session with Crown Castle International jumping 0.65% to $190.97 on Monday, after four consecutive sessions in a row of losses. NYSE Composite jumped 0.9% to $16,844.75, following the last session’s upward trend on what was a somewhat positive trend exchanging session today.

Volume

Today’s last reported volume for Crown Castle International is 1437620, 1.99% above its average volume of 1409440.

Crown Castle International’s last close was $189.73, 7.28% below its 52-week high of $204.62.

Crown Castle International’s Sales

Crown Castle International’s sales growth is 8.8% for the ongoing quarter and 9.6% for the next. The company’s growth estimates for the current quarter and the next is 100% and 126.5%, respectively.

Crown Castle International’s Revenue

Year-on-year quarterly revenue growth grew by 4.5%, now sitting on 5.9B for the twelve trailing months.

Volatility

Crown Castle International’s last week, last month’s, and last quarter’s current volatility was a positive 0.12%, a negative 0.12%, and a positive 0.89%, respectively.

Crown Castle International’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.86% (last week), 0.94% (last month), and 0.89% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Crown Castle International’s stock is considered to be overbought (>=80).

Crown Castle International’s Stock Yearly Top and Bottom Value

Crown Castle International’s stock is valued at $190.97 at 08:34 EST, under its 52-week high of $204.62 and way higher than its 52-week low of $146.15.

Crown Castle International’s Moving Average

Crown Castle International’s worth is under its 50-day moving average of $196.70 and above its 200-day moving average of $181.66.

More news about Crown Castle International.

7. ANSYS (ANSS) – Premarket: -1.38%

NASDAQ Composite ended the session with ANSYS rising 1.03% to $365.02 on Monday, after two successive sessions in a row of losses. NASDAQ Composite rose 1.23% to $15,129.50, following the last session’s upward trend on what was an all-around bullish trend exchanging session today.

Volume

Today’s last reported volume for ANSYS is 370710, 6.68% above its average volume of 347492.

ANSYS’s last close was $361.31, 12.56% under its 52-week high of $413.19.

The company’s growth estimates for the ongoing quarter is 0.6% and a drop 0.7% for the next.

ANSYS’s Revenue

Year-on-year quarterly revenue growth grew by 19.1%, now sitting on 1.74B for the twelve trailing months.

Volatility

ANSYS’s last week, last month’s, and last quarter’s current volatility was 0.31%, 0.14%, and 1.21%, respectively.

ANSYS’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.08% (last week), 0.89% (last month), and 1.21% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

ANSYS’s stock is considered to be overbought (>=80).

ANSYS’s Stock Yearly Top and Bottom Value

ANSYS’s stock is valued at $365.02 at 08:34 EST, way under its 52-week high of $413.19 and way higher than its 52-week low of $292.79.

ANSYS’s Moving Average

ANSYS’s value is higher than its 50-day moving average of $360.24 and above its 200-day moving average of $349.96.

More news about ANSYS.

8. Brookfield (BAM) – Premarket: -1.33%

NYSE Composite ended the session with Brookfield rising 1.12% to $56.96 on Monday, following the last session’s downward trend. NYSE Composite rose 0.9% to $16,844.75, following the last session’s upward trend on what was a somewhat bullish trend trading session today.

Volume

Today’s last reported volume for Brookfield is 1475010, 51.4% below its average volume of 3035130.

Brookfield’s last close was $56.33, 2.59% below its 52-week high of $57.83.

Brookfield’s Sales

Brookfield’s sales growth is 30.6% for the ongoing quarter and a decline by 64.9% for the next. The company’s growth estimates for the present quarter and the next is 274.4% and 660%, respectively.

Brookfield’s Revenue

Year-on-year quarterly revenue growth grew by 53.9%, now sitting on 69.95B for the twelve trailing months.

Volatility

Brookfield’s last week, last month’s, and last quarter’s current volatility was 1.04%, 0.11%, and 1.11%, respectively.

Brookfield’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.77% (last week), 1.53% (last month), and 1.11% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Brookfield’s stock is considered to be oversold (<=20).

Brookfield’s Stock Yearly Top and Bottom Value

Brookfield’s stock is valued at $56.96 at 08:34 EST, under its 52-week high of $57.83 and way higher than its 52-week low of $29.09.

Brookfield’s Moving Average

Brookfield’s value is above its 50-day moving average of $53.33 and way higher than its 200-day moving average of $48.02.

More news about Brookfield.

9. Marathon (MARA) – Premarket: -1.24%

NASDAQ Composite ended the session with Marathon jumping 10.99% to $40.20 on Monday, following the last session’s downward trend. NASDAQ Composite rose 1.23% to $15,129.50, following the last session’s upward trend on what was an all-around up trend trading session today.

Volume

Today’s last reported volume for Marathon is 12807400, 24.39% above its average volume of 10296000.

Marathon’s last close was $36.22, 37.28% under its 52-week high of $57.75.

Marathon’s Revenue

Year-on-year quarterly revenue growth grew by 1444.8%, now sitting on 12.92M for the twelve trailing months.

Volatility

Marathon’s last week, last month’s, and last quarter’s current volatility was a positive 3.07%, a negative 0.56%, and a positive 4.84%, respectively.

Marathon’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 9.07% (last week), 4.26% (last month), and 4.84% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Marathon’s stock is considered to be overbought (>=80).

Marathon’s Stock Yearly Top and Bottom Value

Marathon’s stock is valued at $40.20 at 08:34 EST, way under its 52-week high of $57.75 and way above its 52-week low of $1.48.

Marathon’s Moving Average

Marathon’s worth is way higher than its 50-day moving average of $29.17 and way higher than its 200-day moving average of $32.67.

More news about Marathon.

10. Riot Blockchain (RIOT) – Premarket: -1.19%

NASDAQ Composite ended the session with Riot Blockchain jumping 6.31% to $38.57 on Monday while NASDAQ Composite jumped 1.23% to $15,129.50.

Volume

Today’s last reported volume for Riot Blockchain is 11752600, 6.44% above its average volume of 11040700.

Riot Blockchain’s last close was $36.28, 54.36% under its 52-week high of $79.50.

The company’s growth estimates for the current quarter and the next is 116.1% and 775%, respectively.

Riot Blockchain’s Revenue

Year-on-year quarterly revenue growth grew by 872.2%, now sitting on 32.89M for the twelve trailing months.

Volatility

Riot Blockchain’s last week, last month’s, and last quarter’s current volatility was a positive 3.74%, a negative 0.60%, and a positive 5.18%, respectively.

Riot Blockchain’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 8.84% (last week), 4.41% (last month), and 5.18% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Riot Blockchain’s stock is considered to be overbought (>=80).

Riot Blockchain’s Stock Yearly Top and Bottom Value

Riot Blockchain’s stock is valued at $38.57 at 08:34 EST, way below its 52-week high of $79.50 and way above its 52-week low of $2.35.

Riot Blockchain’s Moving Average

Riot Blockchain’s worth is way higher than its 50-day moving average of $32.57 and under its 200-day moving average of $39.49.

Previous days news about Riot Blockchain

  • Traders prepare for Bitcoin breakout through riot blockchain options. According to Benzinga on Friday, 27 August, "RIOT Price Action: Shares of Riot Blockchain were trading up 6.39% at $38.60 Friday afternoon."

More news about Riot Blockchain.

Stay up to date with our premarket winners and losers daily report

LEAVE A REPLY

Please enter your comment!
Please enter your name here